Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies

A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis

(2017) Leslie Goo et al.   PLoS Pathogens

Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals

(2016) Sandra Henein et al.   JOURNAL OF INFECTIOUS DISEASES

Recognition determinants of broadly neutralizing human antibodies against dengue viruses

(2015) Alexander Rouvinski et al.   NATURE

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

(2015) Sri Rezeki Hadinegoro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing

(2015) Kimberly A. Dowd et al.   mBio

The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response

(2015) Jacky Flipse et al.   PLoS Neglected Tropical Diseases

Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar

(2014) Khin Saw Aye et al.   HUMAN PATHOLOGY

Combined Effects of the Structural Heterogeneity and Dynamics of Flaviviruses on Antibody Recognition

(2014) K. A. Dowd et al.   JOURNAL OF VIROLOGY

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

(2014) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

Dendritic Cells in Dengue Virus Infection: Targets of Virus Replication and Mediators of Immunity

(2014) Michael A. Schmid et al.   Frontiers in Immunology

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

(2013) Maria G. Guzman et al.   ARCHIVES OF VIROLOGY

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein

(2013) S. A. Smith et al.   mBio

Role of CD61+ cells in thrombocytopenia of dengue patients

(2012) Sansanee Noisakran et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody

(2012) E. P. Teoh et al.   Science Translational Medicine

Degrees of maturity: the complex structure and biology of flaviviruses

(2012) Theodore C Pierson et al.   Current Opinion in Virology

Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fc  Receptor and Complement-Dependent Effector Mechanisms

(2011) M. R. Vogt et al.   JOURNAL OF VIROLOGY

Partial maturation: an immune-evasion strategy of dengue virus?

(2011) Izabela A. Rodenhuis-Zybert et al.   TRENDS IN MICROBIOLOGY

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

(2010) Martina Beltramello et al.   Cell Host & Microbe

Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane Fusion

(2009) I.-M. Yu et al.   JOURNAL OF VIROLOGY